Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Shionogi Receives a Contract Through BARDA's Project BioShield
Published 1 month, 1 week ago
Description
In today's Pharmaceutical Executive Daily, Shionogi receives a contract worth up to $482 million to bolster U.S. preparedness against drug-resistant bacterial threats, Roche and C4 Therapeutics expand their long-standing partnership into a new collaboration to develop degrader-antibody conjugates for oncology, and Pharmaceutical Executive profiles AstraZeneca CFO Aradhana Sarin on how she approaches the role as a strategic catalyst for growth.